QA: Centessa Pharmaceuticals plc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001847903_2024_Centessa_Pharmaceuticals_plc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001847903, Centessa Pharmaceuticals plc

  xvar xval
0 AssetsCurrent 315,092,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,039,000
3 remainder_Assets 44,115,000
4 LiabilitiesCurrent 39,385,000
5 LiabilitiesNoncurrent 84,617,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 53,731,000
9 ResearchAndDevelopmentExpense 124,405,000
10 remainder_Expenses -15,150,000
11 remainder_Revenues 6,853,000
12 remainder_NetIncome 5,048,000
13 remainder_ComprehensiveNetIncome 2,990,000
  yvar yval
0 Assets 360,246,000
1 Liabilities 124,002,000
2 Expenses 162,986,000
3 Revenues 6,853,000
4 StockholdersEquity 236,244,000
5 NetIncome -151,085,000
6 ComprehensiveNetIncome -149,590,000
7 BaseVar 331,062,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.51
9 EconomicCapitalRatio 2.68

Edgar->Model Mapping

Feature Distribution